Achillion Pharmaceuticals, Inc.New Haven, CT, United States (NASDAQ (GM): ACHN)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Achillion Financial Statements

Achillion Financial Information

Company Type Public
Single Location
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Achillion Income Statement

  2007 2006 2005
Revenue ($ mil.) 4.0 3.3 8.5
Gross Profit ($ mil.) -- -- --
Operating Income ($ mil.) (30.6) (24.3) (12.7)
Total Net Income ($ mil.) (28.1) (24.1) (13.6)
Diluted EPS (Net Income) (1.80) (9.35) (4.12)
More Achillion financial information

Achillion Stock Quote & Chart

09/05/08 14:59:13 EST • NASDAQ • 2.14 • Decreased by -0.1201 • Decreased by -5.3142 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Achillion Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 22.52 3.66 1.55
Price/Earnings Ratio -- 15.34 15.75
Price/Book Ratio 4.31 2.93 1.49
Price/Cash Flow Ratio -- 12.16 9.68
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Achillion Financial Ratios

Achillion Competitive Intelligence

GlaxoSmithKline Johnson & Johnson Roche
Annual Sales ($ mil.) 22,716.0 61,095.0 34,465.2
Employees 103,401 119,200 74,372
Market Cap ($ mil.) -- 198,797.7 --

Competitive Landscape